Commercial development is underway for a third E. coli O157:H7 vaccine for cattle to help prevent human illnesses with a Nebraska field trial set to begin soon.
Two North
The two North American vaccines developed since 2010 to reduce the dangerous E. coli in cattle by as much as 98 percent are still in limited demand in the marketplace.
